Médecins pour Ultrason à l'étranger — Page 14

Dr. Lee Sanggu, MD, PhD, is a neurosurgeon. He is the Honorary Medical Director and Director of the Spine Center. He is also a Professor of Neurosurgery at Gachon University Gil Medical Center.

Clinical focus includes spine tumors, spinal disorders, minimally invasive spine surgery, and cervical disorders. Procedures include PEN, PNP, selective nerve block, microscopic or endoscopic discectomy, artificial disc replacement, minimally invasive spinal fusion, and vertebroplasty.

He earned a PhD in Medicine from Hanyang University. He served as Chief of Neurosurgery at the Veterans Health Service Medical Center. He is an executive board member of KNS, KNTS, and KSNS. He has served as Vice President and President of KSCS. He is a past president of KOMISS, KAME, and KSPNS. He is an AOSpine Asia Pacific Committee member and a full member of NASS. He was listed in Marquis Who’s Who in 2010.

Spécialisations

Radiologie de l'abdomen

Radiologie Doppler

Radiologie obstétricale

Radiologie du sein

Radiologie musculo-squelettique

Radiologie pédiatrique

Neuroradiologie

Procédures interventionnelles non vasculaires

Oui

Spécialisations

Tumeurs cérébrales

Chirurgie de l'anévrisme

Chirurgie de l'hypophyse

Chirurgie de la colonne vertébrale

Hernies de la taille, du cou et du dos

Tumeurs de la colonne vertébrale

Fractures de la colonne vertébrale

Chirurgie des nerfs périphériques

Dr. Nurana Guliyeva is a gastroenterologist at the Biological Medicine Integrative Health Center in Baku. She specializes in treating viral hepatitis, cirrhosis, and complex autoimmune liver diseases. Dr. Guliyeva completed an internship in microbiology and infectious diseases at Ege University in Turkey. She focuses on digestive health, including stomach, intestine, and pancreas disorders.

• Trained at Ege University and Hacettepe Hospital in Turkey.
• Treats viral hepatitis A, B, C, and D alongside drug-induced liver poisoning.
• Performs specialized procedures like colon hydrotherapy and gastric polyp removal.
• Works at an integrative health center treating over 84,000 patients annually.

Le médecin est un oncochirurgien accompli avec une vaste expérience en urologie. En tant que chef du département d'urologie de Samsung, le médecin a dirigé de nombreuses procédures chirurgicales innovantes et a contribué à des avancées significatives dans le domaine. Le médecin est reconnu pour son expertise en techniques mini-invasives et a joué un rôle clé dans le développement de nouveaux protocoles de traitement du cancer. Le médecin est très estimé pour son engagement envers les soins aux patients et a reçu de nombreuses distinctions pour ses contributions à la recherche médicale et à l'éducation.<\/p>

Dr. José Miguel Esteban Lopez-jamar is a pioneer of endoscopic ultrasound in Spain. He heads the Digestive Endoscopy and Digestive Diseases Units at Hospital Ruber Internacional. Dr. Lopez-jamar specializes in complex interventional endoscopy and minimally invasive treatments. He treats patients at a JCI-accredited hospital ranked among Spain’s top 6 medical centers.

• Served as the Head of Endoscopy at Hospital Clínico San Carlos.
• Completed specialized training at centers in Amsterdam, Marseille, and Shanghai.
• Expert in Barrett’s esophagus and endoscopic obesity treatments.
• Member of the European Society of Gastrointestinal Endoscopy (ESGE).

Dr. Kim Taekhyeon is a gastrointestinal surgeon and the Chief of Gastrointestinal Surgery at Naeun Hospital. He received his M.D. and M.S. from Chung-Ang University College of Medicine. He completed an internship at Sungae Hospital and a general surgery residency at Chung-Ang University Hospital. He then finished a fellowship in gastrointestinal surgery at Seoul St. Mary’s Hospital. He previously served as an attending surgeon at Gwangmyeong Sungae Hospital.

His research covers survivin and HSP90 in colorectal cancer, second primary cancers in patients with gastric cancer, and Borrmann type IV gastric carcinoma. He reported outcomes of laparoscopic totally extraperitoneal inguinal hernia repair in 92 cases. His clinical practice includes cancers and diseases of the stomach, esophagus, and small bowel. He also treats hernias, gallstones and cholecystitis, appendicitis, anal disease, varicose veins, and burns.

Dr. Yu Yeonghun is a gastrointestinal surgeon with a Ph.D. in Medicine. He specializes in hepato-pancreato-biliary (HPB) diseases and cancers. His focus includes liver, pancreas, biliary tract, and gallbladder cancers, as well as cholelithiasis and other gallbladder diseases.

He completed his internship and general surgery residency at CHA Bundang Medical Center. He then finished an HPB surgery fellowship at Samsung Medical Center. He has served as Clinical Assistant Professor of Surgery at Konkuk University Choongju Hospital and at Samsung Medical Center. He later became Professor of Surgery at Eulji University Hospital.

He is a Lifetime Member of The Korean Surgical Society and the Korean Association of Hepato-Biliary-Pancreatic Surgery (KAHBPS). He serves on the KAHBPS Planning Committee and Tumor Registry Committee.

Dr. Beni Boursi is a leading oncologist at Sheba Medical Center. He founded the ECOG-ACRIN Microbiome Working Group. He specializes in treating gastrointestinal cancers using innovative microbial modulation. Dr. Boursi is board certified in internal medicine and medical oncology. He earned his medical degree with highest honors from Tel Aviv University.

• Completed oncology fellowships at the University of Pennsylvania.
• Trained in medical oncology at MD Anderson and Mayo Clinic.
• Developed predictive models for early colorectal and pancreatic cancer diagnosis.
• Published research on microbiome-oncology in the prestigious journal Science.

Dr. Abraham Avigdor is the Director of the Institute of Hematology at Sheba Medical Center. He is a global authority on lymphoma, CAR-T therapy, and complex blood cancers. Dr. Avigdor founded the Israeli Lymphoma Working Group. He helps lead a clinic ranked 7th worldwide by Newsweek in 2026.

• Authored over 130 scientific publications on hemato-oncology and cellular therapy.
• Pioneered the integration of CAR-T cell therapy for lymphoma and myeloma.
• Leads allogeneic and autologous bone marrow transplantation programs.
• Served as the Chairman of the Israeli Lymphoma Study Group.

Dr. Roy Mashiach is the Director of Gynecology at Sheba Medical Center in Israel. He specialized in minimally invasive gynecologic surgery and fertility-preserving procedures. Dr. Mashiach received the Daniel F. Kott Award for surgical innovation from the AAGL.

• Serves as the Chairman of the Israeli Society of Gynecological Endoscopy.
• Consistently named among the Best Doctors in Israel by Forbes.
• Specializes in laparoscopic hysterectomy and robot-assisted myoma removal.
• Works at Sheba Medical Center, ranked among the world’s top 10 hospitals.

Dr. Hila Magen is a leading Israeli hemato-oncologist at Sheba Medical Center. She heads the Multiple Myeloma and Amyloidosis Unit. Dr. Magen specializes in treating complex plasma cell disorders and high-risk myeloma. She is a principal investigator for innovative point-of-care CAR-T therapy programs. Her work brings advanced immunotherapies into routine clinical care.

• Authored over 100 scientific publications and landmark myeloma studies.
• Completed fellowships at MD Anderson and University of Arkansas for Medical Sciences.
• Performs CAR-T cell therapy and bone marrow transplantations.
• Works at Sheba Medical Center, ranked 7th worldwide in 2026 by Newsweek.

Dr. Avichai Shimoni is the Director of Bone Marrow Transplantation at Sheba Medical Center. He treats complex blood cancers. He completed a specialized fellowship at the MD Anderson Cancer Center. Dr. Shimoni uses allogeneic and autologous transplants for high-risk patients. He is a professor and Chairman of Hematology at Tel Aviv University.

• Named among Israel’s Best Doctors by Forbes for 2025 and 2026.
• Authored over 250 scientific papers on cellular therapies and transplantation.
• Provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma.
• Works at Sheba Medical Center, a top-10 hospital globally per Newsweek.

Dr. Jair Bar is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He specializes in treating advanced non-small cell lung cancer using personalized immunotherapy and targeted treatments. Dr. Bar holds a PhD in Molecular Biology and leads a research lab focused on immunotherapy resistance.

• Chair of the Israel Lung Cancer Group.
• Board-certified in both Medical Oncology and Radiotherapy Oncology.
• Treats patients at Sheba Medical Center, a top-10 globally ranked hospital.
• Uses molecular and genetic profiling to create precise cancer treatment plans.

Le médecin est un cardiologue renommé avec plus de 20 ans d'expérience dans le domaine de la médecine cardiovasculaire. Spécialisé en cardiologie interventionnelle, le médecin a réalisé plus de 5 000 cathétérismes cardiaques et poses de stents réussis. Le médecin est certifié en cardiologie et en médecine interne, ayant complété une bourse dans un institut cardiaque de premier plan. De plus, le médecin a contribué à de nombreuses revues à comité de lecture et participe activement à la recherche clinique axée sur les traitements innovants des maladies cardiaques.<\/p>

Le médecin est un gynécologue hautement qualifié avec une spécialisation en oncogynécologie, offrant des soins experts dans le diagnostic et le traitement des cancers gynécologiques. Avec une vaste expérience dans les approches chirurgicales et non chirurgicales, le médecin s'engage à faire progresser la santé des femmes grâce à des traitements innovants et des soins compatissants.<\/p>

Le médecin est un oncogynécologue accompli avec une vaste expérience dans le traitement des cancers gynécologiques. Spécialisé dans les techniques chirurgicales avancées et les plans de traitement personnalisés, le médecin a contribué de manière significative à l'amélioration des résultats des patients. Avec de nombreuses publications dans des revues à comité de lecture, le médecin est reconnu pour son expertise dans les procédures mini-invasives et a été conférencier principal lors de conférences internationales.<\/p>

Le médecin est certifié par le conseil en oncologie gynécologique et est activement impliqué dans la recherche clinique, se concentrant sur les thérapies innovantes et les méthodes de détection précoce. Le médecin est affilié à une institution médicale de premier plan et collabore avec des équipes multidisciplinaires pour fournir des soins complets.<\/p>

Dr. Zohar Dotan heads the Urology Department at Sheba Medical Center in Israel. He is a primary pioneer of robotic and laparoscopic urologic surgery. He specializes in treating complex cancers of the kidney, prostate, and bladder. Dr. Dotan leads the Israeli Uro-Oncology Society and holds a PhD in Genetics.

• Completed a specialized uro-oncology fellowship at Memorial Sloan Kettering in New York.
• Performs robotic radical nephrectomy and da Vinci robotic prostatectomy.
• Authored over 50 scientific publications on advanced urologic cancer treatments.
• Works at Sheba Medical Center, ranked 7th best hospital globally by Newsweek.

Prof. Gil Raviv is a specialist in andrology and reconstructive urology at Sheba Medical Center. Forbes named him among the Best Doctors in Israel. He is the director of the Andrology Unit. Dr. Raviv focuses on male infertility, sexual health, and urethral reconstruction. He works at Sheba, a Top 10 world-ranked hospital.

• Performs specialized sperm retrieval techniques including micro-TESE, TESA, and MESA.
• Treats complex conditions like erectile dysfunction, Peyronie’s disease, and azoospermia.
• Uses microsurgical methods and robotic systems for prostate and urological procedures.
• Provides stem cell therapy and shockwave treatment for sexual dysfunction.